HCV D+/R- Kidney Transplantation in the Real-World: Is It Time?
The emergence of direct acting antiviral (DAA) therapy for hepatitis C (HCV) has arguably been one of the most exciting developments in kidney transplantation in the United [...]
hepatitis C
How Cost-Effective is Transplanting Hepatitis C Positive Kidneys?
The scarcity of kidneys for transplantation has led to continued challenges and subsequent changes in kidney allocation policies. Kidneys that previously would have been [...]
Caring for Patients with Hepatitis C and CKD in the Modern Era: The 2018 KDIGO Guideline
Over the last few years, the management of hepatitis C has been revolutionized by the advent of direct antiviral agents (DAA). This has arguably been one of the most [...]
The Future of Hepatitis C and Kidney Transplantation
This is Part 2 of a 2-part series on Hepatitis C and kidney transplantation. Part 1 reviewed the history of HCV, the era of IFN therapy, and the use of DAAs in patients with [...]
Hepatitis C and Kidney Transplantation: Past, Present, and Future
This is Part 1 of a 2-part series on Hepatitis C and kidney transplantation, highlighting some of the exciting breakthroughs impacting this field that have come about as a [...]
Test Your Knowledge: Hepatitis C and the Kidney
In a recent article in the American Journal of Kidney Diseases, Fabrizi et al review hepatitis C virus and kidney disease with focus on cryoglobulinemia. The following [...]